PUBLISHER: The Business Research Company | PRODUCT CODE: 1829901
PUBLISHER: The Business Research Company | PRODUCT CODE: 1829901
Endovascular aneurysm repair (EVAR) devices are sophisticated medical instruments used for the minimally invasive treatment of aneurysms, particularly in the aorta. An aneurysm occurs when a part of a blood vessel wall weakens and bulges, creating a risk of rupture. EVAR devices are designed to prevent rupture by reinforcing the blood vessel and rerouting blood flow away from the weakened area.
The primary types of aneurysms addressed by EVAR devices are abdominal aortic aneurysms (AAA), thoracic aortic aneurysms (TAA), and peripheral aneurysms. An abdominal aortic aneurysm (AAA) refers to an abnormal bulge or dilation in the lower section of the aorta, the body's largest blood vessel that runs through the abdomen. EVAR devices are used with endovascular grafts, stent-grafts, catheters, delivery systems, and imaging systems, and are intended for various end users, including hospitals, ambulatory surgical centers, and specialty clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The endovascular aneurysm repair devices market research report is one of a series of new reports from The Business Research Company that provides endovascular aneurysm repair devices market statistics, including endovascular aneurysm repair devices industry global market size, regional shares, competitors with an endovascular aneurysm repair devices market share, detailed endovascular aneurysm repair devices market segments, market trends and opportunities, and any further data you may need to thrive in the endovascular aneurysm repair devices industry. This endovascular aneurysm repair devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The endovascular aneurysm repair devices market size has grown strongly in recent years. It will grow from $2.43 billion in 2024 to $2.62 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to improved patient outcomes with EVAR procedures, enhanced precision and safety in EVAR technology, favorable reimbursement policies, positive clinical trial results, and regulatory approvals.
The endovascular aneurysm repair devices market size is expected to see strong growth in the next few years. It will grow to $3.53 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to minimally invasive procedures demand, the development of safer and more effective devices, the shift from open surgery to minimally invasive procedures, advances in imaging and diagnostic techniques, and improved surgical outcomes. Major trends in the forecast period include advancements in stent graft technology, enhanced patient outcomes and reduced recovery times, integration of imaging and navigation technologies in EVAR procedures, development of hybrid EVAR devices, and regulatory advancements and approvals for new EVAR devices.
The forecast of 7.7% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on bifurcated stent graft components and delivery system sheaths, sourced from key regions such as Italy and Sweden, which could lead to delayed aortic aneurysm treatments and higher costs for vascular surgeries.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing demand for minimally invasive surgical procedures is expected to drive growth in the endovascular aneurysm repair devices market. Minimally invasive surgeries involve procedures that use specialized tools and techniques with minimal incisions, reducing bodily disruption. The rise in demand for these procedures is due to factors such as faster recovery times, fewer complications, smaller incisions causing less pain, and improved surgical outcomes. Endovascular Aneurysm Repair (EVAR) devices help in these minimally invasive procedures by strengthening blood vessel walls and redirecting blood flow, thereby lowering the risk of aneurysm rupture. For example, in January 2024, Intuitive Surgical Inc., a U.S.-based producer of robotic surgical systems, announced the placement of 415 da Vinci systems in the fourth quarter of 2023, a 12% increase from the previous year. As a result, the growing trend toward minimally invasive surgeries is contributing to the expansion of the endovascular aneurysm repair devices market.
Leading companies in the endovascular aneurysm repair devices market are focusing on developing advanced solutions, such as abdominal stent-graft systems, to improve patient outcomes by enhancing device durability, increasing procedural success rates, and simplifying deployment. An abdominal stent-graft system is a medical device used during endovascular aneurysm repair (EVAR) to treat abdominal aortic aneurysms (AAA). For example, in August 2024, Terumo India, a medical technology company based in India, introduced the TREO Abdominal Stent-Graft System. This innovative solution is designed for treating abdominal aortic aneurysms (AAAs) in adults with suitable anatomies. It features a unique three-piece design that provides both suprarenal and infrarenal active fixation, improving stability and performance during EVAR procedures. Notable features include in situ limb adjustability for accurate deployment, enhanced proximal sealing to prevent leaks, and advanced lock stent technology to reduce the risk of migration.
Stryker Strengthens Neurovascular Portfolio With Acquisition Of Cerus Endovascular
In May 2023, Stryker Corporation, a US-based medical technology company, acquired Cerus Endovascular Ltd. for an undisclosed sum. This acquisition allows Stryker to expand its aneurysm treatment portfolio by incorporating advanced neurointerventional devices, which will help physicians address a wider variety of intracranial aneurysms more effectively. Cerus Endovascular Ltd., a US-based medical device company, specializes in neurovascular products, with a strong focus on treating intracranial aneurysms.
Major players in the endovascular aneurysm repair devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Royal Philips, Boston Scientific, Terumo Corporation, Biotronik, L. Gore & Associates Inc., AorTech International, Teleflex Incorporated, Getinge AB, Cook Medical Group, Lombard Medical Technologies plc, Merit Medical Systems, Penumbra Inc., Volcano Corporation, Endologix Inc., Scranton Gillette Communications, and Medico S.p.A.
North America was the largest region in the endovascular aneurysm repair devices market in 2024. The regions covered in endovascular aneurysm repair devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the endovascular aneurysm repair devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The endovascular aneurysm repair devices market consists of sales of stent grafts, delivery systems, guidewires, anchoring devices, and endograft components. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Endovascular Aneurysm Repair Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on endovascular aneurysm repair devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for endovascular aneurysm repair devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endovascular aneurysm repair devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.